Orphan Drug Status Granted to Promising Mesothelioma Drug

Days after being approved for its first-in-human trials, Verismo’s SynKIR-110 immunotherapy drug has been granted orphan drug designation for the...

from Mesothelioma.net https://ift.tt/OgpIsHu
via IFTTT
Orphan Drug Status Granted to Promising Mesothelioma Drug Orphan Drug Status Granted to Promising Mesothelioma Drug Reviewed by Unknown on September 29, 2022 Rating: 5

No comments:

Powered by Blogger.